Gestational age of 37 to 42 weeks for singleton births; gestational age of 34 to 42 weeks for twins.
Meet additional study related criteria.
You may not be if
Hypoxemia (oxygen saturation \<96% awake or asleep without any supplemental oxygen or respiratory support).
Any clinical signs or symptoms at Screening or immediately prior to the first dosing (Day 1) that are, in the opinion of the Investigator, strongly suggestive of SMA.
Clinically significant abnormalities in hematology or clinical chemistry parameters.
Treatment with an investigational drug given for the treatment of SMA biological agent, or device. Any history of gene therapy, prior antisense oligonucleotide (ASO) treatment, or cell transplantation.
